Clinical Trial Information Request for Protocol 2026P000035 Title ACCOMPLISH-PD: Phase 2, double-blind, placebo-controlled study to evaluate the effectiveness of two doses of AP-472 as adjunctive therapy to levodopa in Parkinson’s disease (PD) participants with motor fluctuations PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone